Beta Caryophyllene-Loaded Nanostructured Lipid Carriers for Topical Management of Skin Disorders: Statistical Optimization, In Vitro and Dermatokinetic Evaluation.

heat emulsification nanostructured lipid carriers skin disorders traditional gel formulation β-caryophyllene

Journal

Gels (Basel, Switzerland)
ISSN: 2310-2861
Titre abrégé: Gels
Pays: Switzerland
ID NLM: 101696925

Informations de publication

Date de publication:
06 Jul 2023
Historique:
received: 28 05 2023
revised: 30 06 2023
accepted: 01 07 2023
medline: 28 7 2023
pubmed: 28 7 2023
entrez: 28 7 2023
Statut: epublish

Résumé

This work aimed to overcome the disadvantages of the oral administration of beta-caryophyllene and boost efficiency by developing a nanostructured lipid carrier for topical administration of the drug in skin disorders. The heat emulsification method was utilized to produce beta-caryophyllene-loaded nanostructured lipid carriers. The newly created formulation was examined for its particle size, entrapment efficiency, and zeta potential after being improved using the Box-Behnken Design. The chosen formulation underwent tests to determine its ex vivo skin retention, dermatokinetic, in vitro release, antioxidant, and confocal laser scanning microscopy study. The findings of the characterization of the nanostructured lipid carriers demonstrated that the particles had a spherical form and a size of 210.86 nm (0.263 polydispersity index). The entrapment efficiency was determined to be 86.74%, and the zeta potential was measured to be -26.97 mV. The in vitro release investigation showed that nanostructure lipid carriers were capable of releasing regulated amounts of beta-caryophyllene for up to 24 hrs. In comparison to the traditional gel formulation, the ex vivo investigation demonstrated a 1.94-fold increase in the skin's capacity to retain the substance. According to the findings of the study, nanostructure lipid carriers loaded with beta-caryophyllene have the potential to be investigated for use as a topical administration method in skin disorders with enhanced skin retention and effectiveness.

Identifiants

pubmed: 37504429
pii: gels9070550
doi: 10.3390/gels9070550
pmc: PMC10378941
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Nanomedicine (Lond). 2019 Apr;14(8):931-954
pubmed: 30925102
Biochim Biophys Acta. 2002 Aug 19;1564(1):21-30
pubmed: 12100992
Mater Sci Eng C Mater Biol Appl. 2021 Feb;119:111548
pubmed: 33321612
J Sep Sci. 2019 Nov;42(22):3413-3420
pubmed: 31529758
Sci Pharm. 2018 Apr 20;86(2):
pubmed: 29677103
Physiol Behav. 2014 Aug;135:119-24
pubmed: 24930711
Commun Integr Biol. 2008;1(1):26-8
pubmed: 19704783
Acta Histochem. 2014 Oct;116(8):1469-79
pubmed: 25457874
Colloids Surf B Biointerfaces. 2021 Oct;206:111945
pubmed: 34216849
Trends Pharmacol Sci. 2002 May;23(5):238-45
pubmed: 12008002
Eur Neuropsychopharmacol. 2014 Apr;24(4):608-20
pubmed: 24210682
Spectrochim Acta A Mol Biomol Spectrosc. 2020 Jul 5;235:118310
pubmed: 32251894
Int J Pharm. 2007 Jun 7;337(1-2):1-24
pubmed: 17475423
Eur J Pharmacol. 2015 Mar 5;750:141-50
pubmed: 25622554
Chem Biol Interact. 2017 May 25;270:9-14
pubmed: 28411027
Phytochemistry. 2006 Nov;67(22):2469-73
pubmed: 16973189
J Agric Food Chem. 2006 Jan 11;54(1):174-81
pubmed: 16390196
Cancer Med. 2016 Oct;5(10):3007-3017
pubmed: 27696789
Regul Toxicol Pharmacol. 2018 Feb;92:338-346
pubmed: 29258925
Br J Pharmacol. 2007 Jul;151(5):618-27
pubmed: 17471174
Drug Deliv. 2016 Oct;23(8):3043-3054
pubmed: 26878398
Curr Drug Metab. 2017;18(5):404-411
pubmed: 28266274
J Liposome Res. 2021 Jun;31(2):158-168
pubmed: 32290733
Drug Dev Ind Pharm. 2018 Dec;44(12):2013-2025
pubmed: 30095009
Int J Pharm. 2014 Jan 30;461(1-2):403-10
pubmed: 24345574
AAPS PharmSciTech. 2009;10(1):172-82
pubmed: 19224372
Artif Cells Nanomed Biotechnol. 2018;46(sup2):755-765
pubmed: 29730964
PLoS One. 2023 Mar 9;18(3):e0281396
pubmed: 36893152
Eur J Pharmacol. 2014 Nov 5;742:118-24
pubmed: 25179573
Phytother Res. 2018 Dec;32(12):2376-2388
pubmed: 30281175
Eur J Pharm Biopharm. 2016 Nov;108:277-288
pubmed: 27449630
Proc Natl Acad Sci U S A. 2008 Jul 1;105(26):9099-104
pubmed: 18574142
Am J Pathol. 2011 Mar;178(3):1153-66
pubmed: 21356367
Curr Pharm Des. 2020;26(36):4569-4579
pubmed: 32534562
Br J Pharmacol. 2010 Jun;160(3):523-9
pubmed: 20590562
J Med Food. 2013 Jun;16(6):471-80
pubmed: 23734999
Exp Gerontol. 2014 Sep;57:81-95
pubmed: 24835194
Pharmazie. 2009 Mar;64(3):177-82
pubmed: 19348340
Eur J Pharm Sci. 2020 Sep 1;152:105438
pubmed: 32598913
Chem Phys Lipids. 2021 Jan;234:105028
pubmed: 33309940

Auteurs

Mohammed Ghazwani (M)

Department of Pharmaceutics, College of Pharmacy, King Khalid University, Abha 61441, Saudi Arabia.

Umme Hani (U)

Department of Pharmaceutics, College of Pharmacy, King Khalid University, Abha 61441, Saudi Arabia.

Mohammed H Alqarni (MH)

Department of Pharmacognosy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al Kharj 11942, Saudi Arabia.

Aftab Alam (A)

Department of Pharmacognosy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al Kharj 11942, Saudi Arabia.

Classifications MeSH